Haloperidol attenuates β-amyloid-induced calcium imbalance in human fibroblasts

A. Palotás, B. Penke, M. Palotás, A. Sz Kenderessy, L. Kemény, E. Kis, G. Vincze, Z. Janka, J. Kálmán

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Antipsychotics are widely used in the treatment of behavioral and psychological symptoms of dementia. A low frequency of Alzheimer's disease in patients with schizophrenia is reported, and it has been proposed that antipsychotic medications, such as haloperidol, may be responsible. Disruption of intracellular calcium levels is considered to play a key role in β-amyloidinduced neurotoxicity in Alzheimer's disease. Haloperidol has also been reported to interact with calcium homeostasis through dopamine-2 and sigma-1 receptors, and other, yet unknown mechanisms. Objective: Therefore, we investigated whether differences in the basal intracellular free calcium levels of cultured cutaneous fibroblasts - cells that do not express dopamine-2 and sigma-1 receptors - derived from sporadic Alzheimer patients and from age-matched control individuals after haloperidol treatment might be present. Methods: Intracellular calcium level was measured in Fura-2AMloaded human fibroblasts by dual wavelength spectrofluorimetry. Results: Alzheimer cells exhibited significantly lower calcium level as compared to the control cultures. Exposure of fibroblasts to β-amyloid peptide resulted in increased calcium concentration of the control cells, but not of Alzheimer fibroblasts. Co-incubation of cultures with a therapeutic dose of haloperidol blocked the β-amyloid-induced elevation of calcium. Conclusion: This finding indicates that haloperidol efficiently countervails ionic imbalance and suggests that it may serve as a potential agent in alleviating neurotoxic effects of β-amyloid peptide.

Original languageEnglish
Pages (from-to)195-199
Number of pages5
JournalSkin Pharmacology and Physiology
Volume17
Issue number4
DOIs
Publication statusPublished - 2004

Fingerprint

Haloperidol
Amyloid
Fibroblasts
Calcium
Antipsychotic Agents
Dopamine
Alzheimer Disease
Behavioral Symptoms
Peptides
Coculture Techniques
Dementia
Schizophrenia
Homeostasis
Therapeutics
Psychology
Skin

Keywords

  • β-amyloid peptide
  • Alzheimer's disease
  • Calcium
  • Fibroblast
  • Fluorescence
  • Haloperidol
  • Schizophrenia

ASJC Scopus subject areas

  • Pharmacology
  • Physiology
  • Dermatology

Cite this

Haloperidol attenuates β-amyloid-induced calcium imbalance in human fibroblasts. / Palotás, A.; Penke, B.; Palotás, M.; Kenderessy, A. Sz; Kemény, L.; Kis, E.; Vincze, G.; Janka, Z.; Kálmán, J.

In: Skin Pharmacology and Physiology, Vol. 17, No. 4, 2004, p. 195-199.

Research output: Contribution to journalArticle

Palotás, A. ; Penke, B. ; Palotás, M. ; Kenderessy, A. Sz ; Kemény, L. ; Kis, E. ; Vincze, G. ; Janka, Z. ; Kálmán, J. / Haloperidol attenuates β-amyloid-induced calcium imbalance in human fibroblasts. In: Skin Pharmacology and Physiology. 2004 ; Vol. 17, No. 4. pp. 195-199.
@article{2ab12e16512f49f088e04374cdb74d74,
title = "Haloperidol attenuates β-amyloid-induced calcium imbalance in human fibroblasts",
abstract = "Background: Antipsychotics are widely used in the treatment of behavioral and psychological symptoms of dementia. A low frequency of Alzheimer's disease in patients with schizophrenia is reported, and it has been proposed that antipsychotic medications, such as haloperidol, may be responsible. Disruption of intracellular calcium levels is considered to play a key role in β-amyloidinduced neurotoxicity in Alzheimer's disease. Haloperidol has also been reported to interact with calcium homeostasis through dopamine-2 and sigma-1 receptors, and other, yet unknown mechanisms. Objective: Therefore, we investigated whether differences in the basal intracellular free calcium levels of cultured cutaneous fibroblasts - cells that do not express dopamine-2 and sigma-1 receptors - derived from sporadic Alzheimer patients and from age-matched control individuals after haloperidol treatment might be present. Methods: Intracellular calcium level was measured in Fura-2AMloaded human fibroblasts by dual wavelength spectrofluorimetry. Results: Alzheimer cells exhibited significantly lower calcium level as compared to the control cultures. Exposure of fibroblasts to β-amyloid peptide resulted in increased calcium concentration of the control cells, but not of Alzheimer fibroblasts. Co-incubation of cultures with a therapeutic dose of haloperidol blocked the β-amyloid-induced elevation of calcium. Conclusion: This finding indicates that haloperidol efficiently countervails ionic imbalance and suggests that it may serve as a potential agent in alleviating neurotoxic effects of β-amyloid peptide.",
keywords = "β-amyloid peptide, Alzheimer's disease, Calcium, Fibroblast, Fluorescence, Haloperidol, Schizophrenia",
author = "A. Palot{\'a}s and B. Penke and M. Palot{\'a}s and Kenderessy, {A. Sz} and L. Kem{\'e}ny and E. Kis and G. Vincze and Z. Janka and J. K{\'a}lm{\'a}n",
year = "2004",
doi = "10.1159/000078823",
language = "English",
volume = "17",
pages = "195--199",
journal = "Skin Pharmacology and Physiology",
issn = "1660-5527",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Haloperidol attenuates β-amyloid-induced calcium imbalance in human fibroblasts

AU - Palotás, A.

AU - Penke, B.

AU - Palotás, M.

AU - Kenderessy, A. Sz

AU - Kemény, L.

AU - Kis, E.

AU - Vincze, G.

AU - Janka, Z.

AU - Kálmán, J.

PY - 2004

Y1 - 2004

N2 - Background: Antipsychotics are widely used in the treatment of behavioral and psychological symptoms of dementia. A low frequency of Alzheimer's disease in patients with schizophrenia is reported, and it has been proposed that antipsychotic medications, such as haloperidol, may be responsible. Disruption of intracellular calcium levels is considered to play a key role in β-amyloidinduced neurotoxicity in Alzheimer's disease. Haloperidol has also been reported to interact with calcium homeostasis through dopamine-2 and sigma-1 receptors, and other, yet unknown mechanisms. Objective: Therefore, we investigated whether differences in the basal intracellular free calcium levels of cultured cutaneous fibroblasts - cells that do not express dopamine-2 and sigma-1 receptors - derived from sporadic Alzheimer patients and from age-matched control individuals after haloperidol treatment might be present. Methods: Intracellular calcium level was measured in Fura-2AMloaded human fibroblasts by dual wavelength spectrofluorimetry. Results: Alzheimer cells exhibited significantly lower calcium level as compared to the control cultures. Exposure of fibroblasts to β-amyloid peptide resulted in increased calcium concentration of the control cells, but not of Alzheimer fibroblasts. Co-incubation of cultures with a therapeutic dose of haloperidol blocked the β-amyloid-induced elevation of calcium. Conclusion: This finding indicates that haloperidol efficiently countervails ionic imbalance and suggests that it may serve as a potential agent in alleviating neurotoxic effects of β-amyloid peptide.

AB - Background: Antipsychotics are widely used in the treatment of behavioral and psychological symptoms of dementia. A low frequency of Alzheimer's disease in patients with schizophrenia is reported, and it has been proposed that antipsychotic medications, such as haloperidol, may be responsible. Disruption of intracellular calcium levels is considered to play a key role in β-amyloidinduced neurotoxicity in Alzheimer's disease. Haloperidol has also been reported to interact with calcium homeostasis through dopamine-2 and sigma-1 receptors, and other, yet unknown mechanisms. Objective: Therefore, we investigated whether differences in the basal intracellular free calcium levels of cultured cutaneous fibroblasts - cells that do not express dopamine-2 and sigma-1 receptors - derived from sporadic Alzheimer patients and from age-matched control individuals after haloperidol treatment might be present. Methods: Intracellular calcium level was measured in Fura-2AMloaded human fibroblasts by dual wavelength spectrofluorimetry. Results: Alzheimer cells exhibited significantly lower calcium level as compared to the control cultures. Exposure of fibroblasts to β-amyloid peptide resulted in increased calcium concentration of the control cells, but not of Alzheimer fibroblasts. Co-incubation of cultures with a therapeutic dose of haloperidol blocked the β-amyloid-induced elevation of calcium. Conclusion: This finding indicates that haloperidol efficiently countervails ionic imbalance and suggests that it may serve as a potential agent in alleviating neurotoxic effects of β-amyloid peptide.

KW - β-amyloid peptide

KW - Alzheimer's disease

KW - Calcium

KW - Fibroblast

KW - Fluorescence

KW - Haloperidol

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=3242805334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242805334&partnerID=8YFLogxK

U2 - 10.1159/000078823

DO - 10.1159/000078823

M3 - Article

VL - 17

SP - 195

EP - 199

JO - Skin Pharmacology and Physiology

JF - Skin Pharmacology and Physiology

SN - 1660-5527

IS - 4

ER -